New York, New York–(Newsfile Corp. – May 18, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American:Read More
You might also be interested in reading TORN Spikes 5% After U.S. Appeals Court Okays End of Another Tornado Cash Lawsuit.